Crinetics Pharmaceuticals(CRNX)
SAN DIEGO, CAPharmaceutical
Focus: Crinetics is a public-stage, San Diego-based specialty pharmaceutical company focused on small-molecule therapeutics for neuroendocrine and rare diseases, with one FDA-approved product (PALSONIFY) recently launched.
Profile data last refreshed 6h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
14
Should You Work at Crinetics Pharmaceuticals?
AI assessmentStrong clinical pipeline and Vertex backing offset pre-profitability volatility; best suited for mission-driven R&D and clinical professionals willing to embrace post-acquisition integration uncertainty.
Why Work Here
- Direct involvement in Phase 3 programs with multiple catalysts: Paltusotine in acromegaly and carcinoid syndrome, plus atumelnant across Cushing syndrome and congenital adrenal hyperplasia.
Data completeness
7/9 — Strong
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$4M
Key Products
Stable
LAUNCH17.5yr
First-in-class somatostatin receptor 2 agonist with >4000-fold selectivity; recently approved and now driving early commercial adoption as sole approved revenue source.
Help build intelligence for Crinetics Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.